Clean the rubber seal of the Obesema pen with an included alcohol swab, then attach a fresh, sterile needle firmly
Focus on nutrition : Take high-protein and fiber-rich foods in your meals to preserve your muscle mass
What the GLP-1 Bone Loss Research Means for Women Over 40 Specifically The research on GLP-1 therapy and bone loss is generating particular clinical attention in the context of women over 40 - and specifically women in perimenopause and menopause - because this population already faces a well-documented accelerated rate of bone density loss driven by estrogen decline
Semaglutide tablets have been approved since 2019 by the United States Food and Drug Administration (FDA) as a treatment of type 2 diabetes (T2D) under the brand name Rybelsus [2, 5]
[1] [4] If swelling occurs while taking a GLP-1 agonist, it is important to consider alternative explanations, including: Concurrent medications (e.g., calcium channel blockers, NSAIDs) Underlying cardiac, renal, or hepatic conditions Dietary changes or increased salt intake Venous insufficiency or lymphatic issues Patients experiencing unexplained swelling should not automatically attribute it to their GLP-1 medication without proper clinical assessment, as other potentially serious causes must be excluded
In a recent article for The Conversation, UConn expert C